miR-122 inhibition in a human liver organoid model leads to liver inflammation, necrosis, steatofibrosis and dysregulated insulin signaling.
To investigate the role of miR-122 in the development and regression of non-alcoholic fatty liver disease (NAFLD) in vitro, we used multicellular 3D human liver organoids developed in our laboratory. These organoids consist of primary human hepatocytes, Kupffer cells, quiescent stellate cells and li...
Saved in:
| Main Authors: | Hossein Sendi, Ivy Mead, Meimei Wan, Marjan Mehrab-Mohseni, Kenneth Koch, Anthony Atala, Herbert L Bonkovsky, Colin E Bishop |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2018-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0200847&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Emerging biotechnologies for engineering liver organoids
by: Junqi Zhao, et al.
Published: (2025-03-01) -
Cover: Liver Chip System to Model Drug-Induced Liver Injury Using Liver Organoids
Published: (2024-01-01) -
Use of organoids technology on study of liver malignancy
by: Beuy Joob, et al.
Published: (2018-01-01) -
Liver organoids: Current advances and future applications for hepatology
by: Yohan Kim, et al.
Published: (2025-02-01) -
Short communication: miRNA122 interrogation via PCR-Free method to track liver recovery
by: Antonio Marín-Romero, et al.
Published: (2025-01-01)